MoneyWorks4Me

Coral Laboratories - Quaterly Results

14 Feb 2023 Evaluate
The topline stands at Rs. 247.27 millions for the December 2022 quarter. The mentioned figure indicates a rise of about 85.57% as against Rs. 133.25 millions during the year-ago period.The company almost doubled its revenue to Rs. 8.58 millions  from Rs. 2.47 millions in the quarter ended December 2022.Operating profit for the quarter ended December 2022 rose to 23.48 millions as compared to 8.52 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 247.27 133.25 85.57 666.81 555.34 20.07 756.11 965.67 -21.70
Other Income 15.01 9.35 60.53 57.34 32.85 74.55 48.14 37.70 27.69
PBIDT 23.48 8.52 175.59 116.31 104.47 11.33 130.28 196.19 -33.59
Interest 1.08 0.09 1100.00 3.20 5.27 -39.28 1.41 0.43 227.91
PBDT 22.78 8.43 170.23 113.49 99.20 14.41 138.46 195.95 -29.34
Depreciation 5.00 5.06 -1.19 15.00 10.50 42.86 19.91 19.83 0.40
PBT 17.78 3.37 427.60 98.49 88.70 11.04 118.55 176.12 -32.69
TAX 9.20 0.90 922.22 25.10 23.70 5.91 28.10 40.58 -30.75
Deferred Tax 0.20 -1.10 -118.18 0.60 -3.30 -118.18 0.60 -4.42 -113.57
PAT 8.58 2.47 247.37 73.39 65.00 12.91 90.45 135.54 -33.27
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 9.50 6.39 48.51 17.44 18.81 -7.28 17.23 20.32 -15.19
Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..